Conference
Part 1 Results of a Dose-Finding Study of Belantamab Mafodotin in Combination with Pomalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)
Authors
Trudel S; McCurdy A; Sutherland HJ; Louzada ML; Venner CP; Mian HS; Kotb R; Othman I; Camacho F; Gul E
Volume
138
Publisher
ELSEVIER
Publication Date
November 23, 2021
DOI
10.1182/blood-2021-14710
Name of conference
63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)
Conference place
GA, Atlanta
Conference start date
December 11, 2021
Conference end date
December 14, 2021
Conference proceedings
BLOOD
ISSN
0006-4971